ArticleHealth services research2026
The All-Payer Claims Database After the Gobeille Supreme Court Decision: Assessing the Impact on Fatal Opioid-Related Overdose Research.
Article in Health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Compiling Comprehensive Databases for Opioid Overdose Monitoring in a Fragmented Health Care System.Health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo determine the consequences of the Gobeille v. Liberty Mutual Supreme Court decision on the representativeness of the Massachusetts all-payer claims database (APCD). The loss of individuals captured in the APCD may vary demographically, geographically, and in the capture of fatal opioid-related overdose (OOD). DATA SOURCES AND STUDY
settingWe used 2013-2021 data from the Massachusetts Public Health Data Warehouse (PHD), which links person-level APCD records to other datasets. The APCD includes commercially-insured health claims mandatorily reported pre-Gobeille. Post-Gobeille, reporting from self-insured plans, a subset of commercially-insured plans, became voluntary. STUDY
designIn a repeated cross-sectional design, we compared the APCD population characteristics in 2015 to each subsequent year 2016-2021. DATA COLLECTION/EXTRACTION
methodsWe compared pre-post Gobeille statewide APCD demographic distributions using standardized mean differences and assessed geographic distribution changes by ZIP Code. We identified fatal OOD using death certificates. We used annual and monthly interrupted time-series models with publicly-available state records as the control to quantify the pre- (2013-2015) and post- (2016-2021) Gobeille changes in the total APCD population and in fatal OOD when linked to the APCD within the PHD. PRINCIPAL
findingsWithin APCD, the commercially-insured population decreased by 38% post-Gobeille. State-level age increased slightly and sex distributions remained stable, while proportions of White non-Hispanic individuals decreased. Suburban ZIP Codes had the highest losses of individuals. In 2021, under 80% of fatal OODs could be linked to the APCD, compared to 95% linkage pre-Gobeille. The change in monthly fatal OOD rates when linked to the APCD was 0.55 persons higher per 100,000 people post-Gobeille (95% CI: 0.05, 1.05) than the change observed in official statistics.
conclusionsThe Gobeille decision negatively impacted APCD geographic and racial representativeness in Massachusetts, which should be addressed to improve external validity in Massachusetts and other states using APCDs to assess health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.